Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) - Total Assets
Based on the latest financial reports, Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) holds total assets worth CN¥5.04 Billion CNY (≈ $737.70 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 688161 total equity for net asset value and shareholders' equity analysis.
Shandong Weigao Orthopaedic Device Co. Ltd. A - Total Assets Trend (2019–2024)
This chart illustrates how Shandong Weigao Orthopaedic Device Co. Ltd. A's total assets have evolved over time, based on quarterly financial data.
Shandong Weigao Orthopaedic Device Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2024)
Shandong Weigao Orthopaedic Device Co. Ltd. A's total assets of CN¥5.04 Billion consist of 84.7% current assets and 15.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 34.8% |
| Accounts Receivable | CN¥263.48 Million | 5.3% |
| Inventory | CN¥686.59 Million | 13.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥99.74 Million | 2.0% |
| Goodwill | CN¥34.47 Million | 0.7% |
Asset Composition Trend (2019–2024)
This chart illustrates how Shandong Weigao Orthopaedic Device Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Shandong Weigao Orthopaedic Device Co. L market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Weigao Orthopaedic Device Co. Ltd. A's current assets represent 84.7% of total assets in 2024, an increase from 81.7% in 2019.
- Cash Position: Cash and equivalents constituted 34.8% of total assets in 2024, down from 56.4% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 13.9% of total assets.
Shandong Weigao Orthopaedic Device Co. Ltd. A Competitors by Total Assets
Key competitors of Shandong Weigao Orthopaedic Device Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.54 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Shanghai Kinetic Medical Co
SHE:300326
|
China | CN¥3.38 Billion |
|
Eurobio Scientific SA
PA:ALERS
|
France | €259.11 Million |
|
EBR Systems Inc
AU:EBR
|
Australia | AU$97.29 Million |
|
PULSION Medical Systems SE
MU:PUS
|
Germany | €35.15 Million |
|
Aroa Biosurgery Ltd
AU:ARX
|
Australia | AU$95.27 Million |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
Shandong Weigao Orthopaedic Device Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.00 | 4.05 | 6.51 |
| Quick Ratio | 4.27 | 3.35 | 5.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.44 Billion | CN¥3.24 Billion | CN¥4.05 Billion |
Shandong Weigao Orthopaedic Device Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Shandong Weigao Orthopaedic Device Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.83 |
| Latest Market Cap to Assets Ratio | 0.34 |
| Asset Growth Rate (YoY) | -2.9% |
| Total Assets | CN¥4.95 Billion |
| Market Capitalization | $1.67 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Weigao Orthopaedic Device Co. Ltd. A's assets below their book value (0.34x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shandong Weigao Orthopaedic Device Co. Ltd. A's assets decreased by 2.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shandong Weigao Orthopaedic Device Co. Ltd. A (2019–2024)
The table below shows the annual total assets of Shandong Weigao Orthopaedic Device Co. Ltd. A from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.95 Billion ≈ $724.05 Million |
-2.91% |
| 2023-12-31 | CN¥5.10 Billion ≈ $745.79 Million |
-15.28% |
| 2022-12-31 | CN¥6.02 Billion ≈ $880.29 Million |
+11.33% |
| 2021-12-31 | CN¥5.40 Billion ≈ $790.67 Million |
+69.54% |
| 2020-12-31 | CN¥3.19 Billion ≈ $466.35 Million |
-0.80% |
| 2019-12-31 | CN¥3.21 Billion ≈ $470.11 Million |
-- |
About Shandong Weigao Orthopaedic Device Co. Ltd. A
Shandong Weigao Orthopaedic Device Co., Ltd. operates as a orthopedic implant medical device and pharmaceutical company. The company offers general consumables, such as clinical care consumables and supplies, infection protection supplies, infusion consumables, indwelling needle, anesthesia respiratory consumables, other operating room consumables, and other clinical consumables; endocrine consum… Read more